News About: Pharm. Industry
Will ‘Zantac’ be substituted by domestic generics?
GSK’s Zantac, the original of ranitidine, went out of stock again. The distribution industry and pharmacies have started to make complaints. Using it as a chance, some generic products are also known to aggressively t...
Pfizer Korea President Dong-soo Lee promoted to GIP Asia Cluster LeadPfizer announced President Dong-soo Lee of Pfizer Korea was appointed as GIP(Global Innovative Pharma) Asia Cluster Lead.
Thus, President Lee will take the lead in growth of th...
|
Capability of blockbuster to change the 7.5:2.5 ratio to 7:3
Is this why people talk up about blockbuster drugs? The recent move of Ildong Pharmaceutical has made the industry feel the importance of blockbusters.
After overcoming an inner struggle cause by the M&A in the begin...
‘Eye-opening growths’ of Yuhan, Green Cross and Hanmi in the 3rd quarterLarge pharmaceutical companies, such as Yuhan Corporation, Green Cross and Hanmi Pharm, overcame the MERS crisis and had eye-opening growths in the 3rd quarter.
According to th...
|
Chong Kun Dang to exclusively sell the first Avodart genericChong Kun Dang has started to sell Dutesmol, a Avodart(dutasteride) generic. This is the first time ever in the domestic industry.
Dutesmol is a hair loss treatment only for me...
|
Bayer Korea, “Korea is a very potential market”Bayer Korea has shown expectation towards potential and co-development of the Korean life science market.
On the 27th, CEO Ingrid Drechsel of Bayer Korea stressed importance of...
|
Hanmi and Ildong’s high sales performance in the 3rd quarterHanmi Pharm and Ildong Pharmaceutical has made performance that is better than what they expected. Their representative products such as Amosartan and Aronamin have grown well, ...
|
Celltrion and Samsung Medison to record the highest market capitalization
It was observed market capitalization of listed companies in the health care industry reached KRW 152.2 trillion. Among pharmaceutical companies, Celltrion recorded the most with KRW 8.62 trillion; among medical devic...
Fueled Crestor generic market preoccupied by CJ and Ildong
In the market of ‘Crestor(rosuvastatin),’ a hyperlipidemia treatment which was jumped in by approximately 50 pharmaceutical companies last year, CJ HealthCare and Ildong Pharmaceutical have succeeded in getting a head...
Largest CSO establishment participated by pharmaceutical companies
The domestically largest CSO(Contract Sales Organizations) is about to be emerged in the pharmaceutical distribution industry.
According to the industry concerned on the 26th, a couple of pharmaceutical companies and...
